earnings missCOAGfinnhub
Hemab Therapeutics Hldgs (COAG) Misses Q2 Earnings Expectations
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreFeatured By
Real-time context
Company earnings results and notable reporting developments.
Hemab Therapeutics Hldgs (NASDAQ:COAG) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreLB Pharmaceuticals (NASDAQ:LBRX) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreZura Bio (NASDAQ:ZURA) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read morePrelude Therapeutics (NASDAQ:PRLD) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreSagimet Biosciences (NASDAQ:SGMT) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreKalaris Therapeutics (NASDAQ:KLRS) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreAura Biosciences (NASDAQ:AURA) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreProtara Therapeutics (NASDAQ:TARA) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreNeurogene (NASDAQ:NGNE) reported quarterly earnings results on August 11, 2026 that fell short of analyst expectations.
Read moreImmunic (NASDAQ:IMUX) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreC4 Therapeutics (NASDAQ:CCCC) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreUpstream Bio (NASDAQ:UPB) reported quarterly earnings results on August 11, 2026 that exceeded analyst expectations.
Read moreSkyWater Technology (NASDAQ:SKYT) reported quarterly earnings results on August 07, 2026 that fell short of analyst expectations.
Read moreNIQ Global Intelligence (NYSE:NIQ) reported quarterly earnings results on August 10, 2026 that exceeded analyst expectations.
Read moreSepterna (NASDAQ:SEPN) reported quarterly earnings results on August 10, 2026 that exceeded analyst expectations.
Read moreOlema Pharmaceuticals (NASDAQ:OLMA) reported quarterly earnings results on August 10, 2026 that fell short of analyst expectations.
Read moreMAIA Biotechnology (AMEX:MAIA) reported quarterly earnings results on August 10, 2026 that fell short of analyst expectations.
Read moreEnanta Pharma (NASDAQ:ENTA) reported quarterly earnings results on August 10, 2026 that fell short of analyst expectations.
Read moreTelos (NASDAQ:TLS) reported quarterly earnings results on August 10, 2026 that exceeded analyst expectations.
Read moreTELA Bio (NASDAQ:TELA) reported quarterly earnings results on August 10, 2026 that fell short of analyst expectations.
Read more